Spektus Pharma

Spektus is a pharmaceutical company focused on development, concentrating on the global central nervous system field. Relying on proprietary drug delivery platforms and technologies, the company explores the clinical value and untapped potential of well-established drugs. Spektus focuses on reformulating marketed molecules, including extended-release formulations of antidepressants, to enhance dosing convenience and patient treatment adherence. The product portfolio centers on oral formulations, adjusting drug release characteristics without altering active ingredients, offering new treatment options for patients and prescribing physicians. Spektus collaborates with other pharmaceutical companies through licensing and commercial partnerships to bring drugs to the North American and European markets. Research and development efforts primarily focus on building an intellectual property protection system around formulation technologies and manufacturing processes.